Drug Injuries
![](https://i0.wp.com/www.johnsonbecker.com/wp-content/uploads/2019/02/Xeljanz.jpg?resize=600%2C450&ssl=1)
Xeljanz Lawsuit
In recent months, pharmaceutical company Pfizer has been facing numerous lawsuits against its prescription drug, Xeljanz. The Xeljanz lawsuits allege that the drug, when taken at a high dosage, poses an increased risk of serious health conditions such as cancer, deep vein thrombosis (DVT), pulmonary embolism (PE), liver damage, and cardiovascular events like heart attack or stroke.
![](https://i0.wp.com/www.johnsonbecker.com/wp-content/uploads/2019/02/viberzi-lawsuit.jpg?resize=600%2C450&ssl=1)
Viberzi Lawsuit
Patients taking Viberzi to treat irritable bowel syndrome may be at risk of suffering from pancreatitis, which could lead to hospitalization or death.
![](https://i0.wp.com/www.johnsonbecker.com/wp-content/uploads/2019/02/actemra-lawsuit.jpg?resize=600%2C450&ssl=1)
Actemra Lawsuit
Many patients are at risk of fatal side effects from taking Actemra, despite marketing efforts by its manufacturer that claim otherwise.
![](https://i0.wp.com/www.johnsonbecker.com/wp-content/uploads/2018/12/FDA-Warns-about-Fourniers-Gangrene-in-Diabetic-Patients.jpg?resize=600%2C450&ssl=1)
Fournier’s Gangrene Lawsuit
The FDA identified that certain type-2 diabetes medications may trigger the onset of a flesh-eating infection known as Fournier’s gangrene.
![](https://i0.wp.com/www.johnsonbecker.com/wp-content/uploads/2018/09/Valsartan-Cancer-Lawsuit.jpg?resize=600%2C450&ssl=1)
Valsartan Cancer Lawsuit
Valsartan is a blood pressure medication that was recalled due to the presence of a carcinogenic ingredient patients were not aware of until this year.
![](https://i0.wp.com/www.johnsonbecker.com/wp-content/uploads/2018/11/gilenya.jpg?resize=600%2C450&ssl=1)
Gilenya Lawsuit
A medication used to treat relapsing multiple sclerosis, Gilenya, poses a threat to patients as symptoms may worsen if they discontinue use.
![Lemtrada and Campath Lawsuit](https://i0.wp.com/www.johnsonbecker.com/wp-content/uploads/Lemtrada-Campath-Lawsuit.jpg?resize=600%2C450&ssl=1)
Lemtrada & Campath Lawsuit
Learn more about the recent FDA “Black Box Warning” on popular multiple sclerosis (MS) and B-cell chronic lymphocytic leukemia (B-CLL) drugs that have been linked to arterial dissection and strokes.
![](https://i0.wp.com/www.johnsonbecker.com/wp-content/uploads/2018/09/Montelukast-Sodium-Tablet-Recall-Lawsuit.jpg?resize=600%2C450&ssl=1)
Montelukast Sodium Tablet Recall Lawsuit
Montelukast sodium tablets were voluntarily recalled because they were mixed up with another medication which could cause injury to an unsuspecting patient.
![Orajel Linked to methemoglobinemia](https://i0.wp.com/www.johnsonbecker.com/wp-content/uploads/2018/05/Orajel-Benzocaine-Lawsuit.jpg?resize=600%2C450&ssl=1)
Orajel & Benzocaine Warning Lawsuit
Consumers were warned by the U.S. Food and Drug Administration (FDA) to immediately stop using benzocaine teething products such as Orajel for babies as it can cause a rare but serious form of methemoglobinemia.
![Mirena Idiopathic Intracranial Hypertension Lawsuit](https://i0.wp.com/www.johnsonbecker.com/wp-content/uploads/2018/05/mirena-Mirena-Idiopathic-Intracranial-Hypertension-Lawsuit.jpg?resize=600%2C450&ssl=1)
Mirena Lawsuit – Idiopathic Intracranial Hypertension
Mirena is an intrauterine device (IUD) for women that has been linked to causing Idiopathic Intracranial Hypertension (also known as, pseudotumor cerebri), a devastating neurological disorder that can lead to irreversible vision impairment and even …